Back to companies
Ernexa Therapeutics Inc.
ERNAUSNASDAQPharmaceuticals & HealthcareErnexa Therapeutics Inc.
Revenue
—
FY2025
Operating income
-$9.3mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API